Plasma volume expansion in patients with heart failure (HF) is associated with neurohumeral activation; symptom and signs of pulmonary congestion and peripheral oedema; an increase in hospitalizations for HF; and cardiovascular mortality. A reduction in plasma volume, as evidenced by haemoconcentration, has recently been suggested to be associated with an improvement in cardiovascular mortality...

Many problems relating to the premature baby have received intensive study during the past few decades. This has resulted in more efficient care of the premature with a subsequent decrease in the mortality rate. It is surprising, however, that there is still so much difference of opinion regarding the feeding of premature babies, not only with respect to the type of food but also to the timing ...

Objective: To detect the effect of late coasting on oocyte quality. Design: Retrospective study. Setting: Samir Abbas Medical Center Materials and methods: Patients where estradiol level was over 4000 pg/ml and late coasting was used as a method to prevent OHSS, and patients where estradiol level was over 4000 pg / ml but no coasting was done Main outcome measure(s) : Oocyte quality. Results: n...

This article refers to ‘Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure’ by E.M. Boorsma et al., published this issue pages 68–78. The Heart Failure Association (HFA) the European Society Cardiology (ESC) recommend sodium–glucose co-transporter 2 inhibitors (SGLT2i) be used type diabetes mellitus either established cardiovascular (CV) disease o...

Heart failure (HF) is a risk factor for the development of chronic kidney disease (CKD) and vice versa, while the two conditions quite often co-exist. About one-third of HF patients suffer from at least mild to moderate CKD and about a quarter of them develop worsening renal function (WRF) during their hospitalization for HF. –4 Renal dysfunction is an independent predictor of adverse prognosis...